Biblio
Export 956 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is F [Clear All Filters]
“Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.”, J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
, “Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1247-1259, 2018.
, “Aging without Dementia is Achievable: Current Evidence from Epidemiological Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 933-942, 2018.
, “Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 571-580, 2018.
, “Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.”, J Alzheimers Dis, vol. 62, no. 2, pp. 841-854, 2018.
, “Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.”, J Alzheimers Dis, vol. 62, no. 2, pp. 841-854, 2018.
, “Alterations of Effective Connectivity Patterns in Mild Cognitive Impairment: An MEG Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 843-854, 2018.
, “Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease, Oligomers, and Inflammation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1261-1276, 2018.
, “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
, “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
, “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
, “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
, “Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays.”, J Alzheimers Dis, vol. 64, no. s1, pp. S659-S672, 2018.
, “Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.
, “Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1353-1364, 2018.
, “Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
, “Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 1, pp. 83-95, 2018.
, “Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.”, J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
, “The Association Between Body Mass Index, and Cognitive, Functional, and Behavioral Declines for Incident Dementia.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1507-1517, 2018.
, “Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.”, J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.
,